Tokyo, Aug. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062389) titled 'Hyperglycemia control test with Syn-rice' on Aug. 1.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Non-randomized Blinding - Open -no one is blinded Control - No treatment

Primary Sponsor: Institute - Fukuyama Hospital

Condition: Condition - Type 2 Diabetes Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Type 2 diabetes is known to cause postprandial hyperglycemia, and blood glucose fluctuations are known to be involved in the progression of diabetic complications. Synthetic rice (Shinrice) is a synthetic rice containing white kidney beans and konjac, and is a food that can be easily eaten by rehydrating it with water. It is known to suppress sugar absorption due to the action of white kidney beans grown in high altitude areas of the UK. This study examines the effects of replacing regular breakfast with this Shinrice. Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - We will examine the benefits of replacing synthetic rice with regular breakfast. Measurement is performed using continuous blood glucose measurement (iPro-2). Under normal diet, blood glucose is first measured for a week. Next, the breakfast rice is replaced with thin rice with the same carbohydrate content, and blood glucose is measured for a week. Interventions/Control_2 - After a 4-week synthetic rice breakfast, the weight is also measured to determine the weight loss effect. Glycoalbumon (GA) measurements are performed along with blood glucose measurements before and after.

Eligibility: Age-lower limit - 20 years-old

Gender - Male and Female Key inclusion criteria - Patients undergoing treatment for type 2 diabetes Key exclusion criteria - 1. HbA1c 9% or more 2. Ketosis Target Size - 20

Recruitment Status: Recruitment status - No longer recruiting Date of protocol fixation - 2025 Year 04 Month 30 Day Date of IRB - 2025 Year 04 Month 30 Day Anticipated trial start date - 2025 Year 05 Month 01 Day Last follow-up date - 2026 Year 04 Month 01 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065989

Disclaimer: Curated by HT Syndication.